Osel Overview

  • Founded
  • 1996
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.48M
Latest Deal Amount
  • Investors
  • 1

Osel General Information


Provider of live biotherapeutic products intended to harness the microbiome to improve health. The company's products address major gastrointestinal, infectious diseases and women's health indications as well as treat abnormal conditions resulting from a disruption of the human microbiome, enabling healthcare providers to find a cure for their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 320 Logue Avenue
  • Mountain View, CA 94043
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Osel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2016 $3.48M 00.000 Completed Generating Revenue
6. Grant 01-Jan-2005 00000 00.000 Completed Generating Revenue
5. Later Stage VC (Series C) 21-Dec-2004 00.000 00.000 Completed Generating Revenue
4. Grant 01-Jan-2003 00000 Completed Generating Revenue
3. Grant 01-Jan-2002 00.000 Completed Generating Revenue
2. Grant 01-Jan-2001 $140K Completed Generating Revenue
1. Grant 01-Jan-1999 $129K Completed Generating Revenue
To view Osel’s complete valuation and funding history, request access »

Osel Executive Team (6)

Name Title Board Seat Contact Info
Ralph Levy President
Tom Parks Director, Product Development
Laurel Lagenaur Ph.D Director, Research
Peter Lee MD Co-Founder & Executive Chairman
Gary Schoolnik Scientific Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

Osel Board Members (4)

Name Representing Role Since
Michael Cannon Self Board Member 000 0000
Peter Lee MD Osel Co-Founder & Executive Chairman 000 0000
Robert Lee Self Board Member 000 0000
Sandy Chau Self Board Member 000 0000
To view Osel’s complete board members history, request access »

Osel Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Osel Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Osel’s complete investors history, request access »